Literature DB >> 1036668

Antibodies to Yersinia enterocolitica in thyroid disease.

L Shenkman, E J Bottone.   

Abstract

The prevalence of elevated antibody titers against Yersinia enterocolitica was studied in normal subjects, patients with a variety of nonthyroidal illnesses, and patients with thyroid disease. In contrast to the low prevalence of antibodies in controls (less than 8%), 48 of 67 patients (75%) with a variety of thyroid disorders had titers greater than 1:8. Antibodies were found in 24 of 36 patients with Graves' disease, five of six with autonomous adenoma, seven of seven with Hashimoto's thyroiditis, three of five with idiopathic primary hypothyroidism, four of 11 with nontoxic nodular goiter, and one of two with thyroid carcinoma. Antibodies to serotype 3 were the most prevalent, occurred in the highest titers, and were found particularly in patients with Graves' disease. These observations indicate that in spite of the infreqent occurrence of yersinia infection in the United States as compared with Scandinavia, patients with thyroid disorders have a higher prevalence of antibodies to Yersinia than normal subjects or patients with other disorders.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1036668     DOI: 10.7326/0003-4819-85-6-735

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

Review 1.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

Review 2.  Hepatitis C and interferon induced thyroiditis.

Authors:  Yaron Tomer
Journal:  J Autoimmun       Date:  2010-05       Impact factor: 7.094

3.  No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study.

Authors:  G Effraimidis; J G P Tijssen; T G A Strieder; W M Wiersinga
Journal:  Clin Exp Immunol       Date:  2011-04-13       Impact factor: 4.330

Review 4.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Lymphoid thyroiditis following immunization with group A streptococcal vaccine.

Authors:  N Tonooka; G A Leslie; M A Greer; J C Olson
Journal:  Am J Pathol       Date:  1978-09       Impact factor: 4.307

6.  Evaluation of a western blot method for the detection of Yersinia antibodies: evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi.

Authors:  Mindy L Rawlins; Cecilia Gerstner; Harry R Hill; Christine M Litwin
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

7.  The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis.

Authors:  W J Penhale; P R Young
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

8.  I.g.A. nephropathy in association with Yersinia enterocolitica.

Authors:  D Cusack; P Martin; T Schinittger; M McCafferky; C Keane; B Keogh
Journal:  Ir J Med Sci       Date:  1983-08       Impact factor: 1.568

9.  Antibodies to Yersinia enterocolitica serotype 3 in thyroid disease.

Authors:  M T Reynolds; C T Keane; G H Tomkin; J C Roberts; T J Lenehan; N S Mair
Journal:  Br Med J       Date:  1978-08-05

10.  Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis?

Authors:  Paolo A Tomasi; Maria P Dore; Giuseppe Fanciulli; Franca Sanciu; Giuseppe Realdi; Giuseppe Delitala
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.